Sun Pharmaceutical Recalls Testosterone Cypionate Injection Due to Labeling Error
Sun Pharmaceutical Industries Inc. is recalling Testosterone Cypionate Injection due to an incorrect lot number on secondary packaging.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The recall is classified as FDA Class III, which indicates a low risk of adverse health consequences. The issue is limited to a packaging labeling error.
Plain-English summary
Sun Pharmaceutical Industries Inc. is recalling 36,275 cartons of Testosterone Cypionate Injection, USP CIII 200mg/ml for intramuscular use. The product is distributed nationwide and is identified by Lot JKX2553A.
The recall was initiated because of an incorrect lot number on the secondary packaging. This is a documentation and labeling issue rather than a defect in the drug product itself.
Consumers and healthcare providers should check their inventory for this specific lot number and packaging. If found, the product should be returned to the distributor or the recalling firm for credit.
The recalled product
- Product
- TESTOSTERONE CYPIONATE (TESTOSTERONE CYPIONATE)
- Brand
- TESTOSTERONE CYPIONATE
- Manufacturer
- SUN PHARMACEUTICAL INDUSTRIES INC
- Category
- Drug — Prescription Injection
- Hazard
- Affected units
- 36,275
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot JKX2553A
UPCs (3)
- 0362756017405
- 0362756015401
- 0362756016408
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · TESTOSTERONE CYPIONATE
- ModerateTestosterone Cypionate Injection Recalled for Insoluble Crystals
FDA (Drugs) · 2025-04-23
- HighTestosterone Cypionate Injection Recalled for Manufacturing Defect
FDA (Drugs) · 2023-04-12
- HighTestosterone Cypionate Injection Recalled for Water Leakage in Manufacturing
FDA (Drugs) · 2022-07-20
- ModerateTestosterone Cypionate Injectable Drug Recalled for Manufacturing Deviations
FDA (Drugs) · 2022-07-13
- HighTestosterone Cypionate Injectable Recalled for Manufacturing Quality Issues
FDA (Drugs) · 2022-06-29
Same manufacturer · SUN PHARMACEUTICAL INDUSTRIES INC
See all →- HighSun Pharmaceutical Recalls Carbamazepine Tablets Due to Manufacturing Deviations
FDA (Drugs) · 2026-08-26
- LowFexofenadine Hydrochloride Tablets 180 mg Recalled for Impurities
FDA (Drugs) · 2026-07-08
- HighPerampanel Prescription Tablets Recalled for Labeling Mix-up
FDA (Drugs) · 2026-07-01
- HighBudesonide inhalation ampules contain black and brown specks and particles
FDA (Drugs) · 2026-06-17
- SevereDoxorubicin liposome injection vials contain glass particulate matter
FDA (Drugs) · 2026-06-17
Same hazard · mis labeling
See all →- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- HighSura Tanmen Ramen Noodles Recalled for Undeclared Fish Allergens
FDA (Food) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02